REFERENCES
- Noris P, Spedini P, Belletti S, Magrini U, Balduini CL.
Thrombocytopenia, giant platelets, and leukocyte inclusion bodies
(May-Hegglin anomaly): clinical and laboratory findings. Am J
Med. 1998;104(4):355-360.
- Althaus K, Greinacher A. MYH9-related platelet disorders. Semin
Thromb Hemost. 2009;35(2):189-203.
- May R. Leukocyteneinschlusse. Deutsch Arch Klin Med.1909;96:1-6.
- Hegglin R. Gleichzeitige konstitutionelle veranderungen an
neurtophilen und thrombocyten. Helv Med Acta. 1945;12:439-440.
- Heath
KE,
Campos-Barros
A,
Toren
A, et al. Nonmuscle myosin heavy chain IIA mutations define a
spectrum of autosomal dominant macrothrombocytopenias: May-Hegglin
anomaly and Fechtner, Sebastian, Epstein, and Alport-like
syndromes. Am J Hum Genet . 2001;69(5):1033-1045.
- Saito H, Kunishima S. Historical hematology: May-Hegglin
anomaly. Am J Hematol. 2008;83(4):304-306.
- Kunishima S, Matsushita T, Shiratsuchi M, et al. Detection of unique
neutrophil non-muscle myosin heavy chain-A localization by
immunofluorescence analysis in MYH9 disorder presented with
macrothrombocytopenia without leukocyte inclusions and
deafness. Eur J Haematol. 2005(1);74:1-5.
- Kunishima S, Matsushita T, Kojima T, et al. Immunofluorescence
analysis of neutrophil nonmuscle myosin heavy chain-A in MYH9
disorders: association of subcellular localization with MYH9
mutations. Lab Invest. 2003;83(1):115-122.
- Balduini CL, Savoia A, Seri M. Inherited thrombocytopenias frequently
diagnosed in adults. J Thromb Haemost . 2013;11(6):1006-1019.
- Thakral B, Rojanapremsuk T, Saluja K, Eldibany M. Misdiagnosed MYH9
related inherited macrothrombocytopenia with an inadvertent
splenectomy. Pathology. 2015;47(4):377-379.
- Rabbolini DJ, Chun Y, Latimer M, et al. Diagnosis and treatment
of MYH9- RD in an Australasian cohort with
thrombocytopenia. Platelets . 2018;29(8):793-800.
- Yoshinari
M,
Kunishima
S,
Miyabayashi
S,
Saito
H,
Tsuchiya
S. A unique immunofluorescence method promotes accurate diagnosis in
MYH9 disorders: a case report. J Pediatr Hematol Oncol.2004;26(9):579-583.
- Kodama
R,
Taketani
T,
Kunishima
S, et al. A rare case of MYH9 disorders presenting with
macrothrombocytopenia and deafness caused by MYH9-R702C mutation.Thromb Res. 2009;124(4):508-511.
- Wasano
K,
Matsunaga
T,
Ogawa
K,
Kunishima
S. Late onset and high-frequency dominant hearing loss in a family
with MYH9 disorder. Eur Arch Otorhinolaryngol.2016;273(11):3547-3552.
- Murayama
S,
Akiyama
M,
Namba
H,
Wada
Y,
Ida
H,
Kunishima
S. Familial cases with MYH9 disorders caused by MYH9 S96L mutation.Pediatr
Int. 2013;55(1):102-104.
- Pecci
A,
Klersy
C,
Gresele
P, et al. MYH9 disease: a novel prognostic model to predict the
clinical evolution of the disease based on genotype-phenotype
correlations. Hum Mutat. 2014;35(2):236-247.
- Sirachainan
N,
Komwilaisak
P,
Kitamura
K,
Hongeng
S,
Sekine
T,
Kunishima
S. The first two cases of MYH9 disorders in Thailand: an
international collaborative study. Ann Hematol.2015;94(4):707-709.
- Arrondel
C,
Vodovar
N,
Knebelmann
B, et al. Expression of the nonmuscle myosin heavy chain IIA in the
human kidney and screening for MYH9 mutations in Epstein and Fechtner
syndromes.J
Am Soc Nephrol. 2002;13(1):65-74.
- Dong
F,
Li
S,
Pujol-Moix
N, et al. Genotype-phenotype correlation in MYH9 thrombocytopenia.Br J Haematol. 2005;130(4):620-627.
- Sun
XH,
Wang
ZY,
Cao
LJ, et al. Clinical features and gene analyses of six patients with
MYH9 disease.Zhonghua Xue
Ye Xue Za Zhi. 2012;33(7):552-555.
- Sun
XH,
Wang
ZY,
Yang
HY, et al. Clinical, pathological, and genetic analysis of ten
patients with MYH9 disease. Acta Haematol. 2013;129(2):106-113.
- Saposnik B, Binard S, Fenneteau O, et al. Mutation spectrum and
genotype-phenotype correlations in a large French cohort of
MYH9-Related Disorders. Mol Genet Genomic Med.2014;2(4):297-312.
- Pecci A, Verver EJ, Schlegel N, et al. Cochlear implantation is safe
and effective in patients with MYH9-related disease. Orphanet J
Rare Dis. 2014;9:100.